The company said that these observations are procedural in nature and will be responded to within the stipulated time.
US FDA slaps Aurobindo Pharma#39;s Telangana injectable facility with 7 observations
Estimated read time
1 min read
You May Also Like
More From Author
Comments are closed.
+ There are no comments
Add yours